Pharmaceutics, Free Full-Text

The history of brain drug delivery is reviewed beginning with the first demonstration, in 1914, that a drug for syphilis, salvarsan, did not enter the brain, due to the presence of a blood–brain barrier (BBB). Owing to restricted transport across the BBB, FDA-approved drugs for the CNS have been generally limited to lipid-soluble small molecules. Drugs that do not cross the BBB can be re-engineered for transport on endogenous BBB carrier-mediated transport and receptor-mediated transport systems, which were identified during the 1970s–1980s. By the 1990s, a multitude of brain drug delivery technologies emerged, including trans-cranial delivery, CSF delivery, BBB disruption, lipid carriers, prodrugs, stem cells, exosomes, nanoparticles, gene therapy, and biologics. The advantages and limitations of each of these brain drug delivery technologies are critically reviewed.

Tablet, Pharmaceutics, ESIC pharmacist live classes

PDF) PHARMACEUTICS-I

Full Package Medicines Vitamins Purchase Delivery Stock Vector

Top 50 deficiencies in CTD Dossier - Pharmaceutical

UCC Pharmacy School on X: Delighted to announce our upcoming

Clarification And Filtration In Pharmaceutics Pdf - Colaboratory

Text Book of Clinical Pharmacokinetics and Pharmacotherapeutic

CanadaCSPS (@CanadaCSPS) / X

QbD Application in Pharmaceutical Development for Nano Formulation

Pharmacy Related Text Medical Background Pharmacy Stock Vector